Infection Reduces B Lymphopoiesis in Bone Marrow and Truncates Compensatory Splenic Lymphopoiesis through Transitional B-Cell Apoptosis

English version České info

African trypanosomes of the Trypanosoma brucei species are extracellular protozoan parasites that cause the deadly disease African trypanosomiasis in humans and contribute to the animal counterpart, Nagana. Trypanosome clearance from the bloodstream is mediated by antibodies specific for their Variant Surface Glycoprotein (VSG) coat antigens. However, T. brucei infection induces polyclonal B cell activation, B cell clonal exhaustion, sustained depletion of mature splenic Marginal Zone B (MZB) and Follicular B (FoB) cells, and destruction of the B-cell memory compartment. To determine how trypanosome infection compromises the humoral immune defense system we used a C57BL/6 T. brucei AnTat 1.1 mouse model and multicolor flow cytometry to document B cell development and maturation during infection. Our results show a more than 95% reduction in B cell precursor numbers from the CLP, pre-pro-B, pro-B, pre-B and immature B cell stages in the bone marrow. In the spleen, T. brucei induces extramedullary B lymphopoiesis as evidenced by significant increases in HSC-LMPP, CLP, pre-pro-B, pro-B and pre-B cell populations. However, final B cell maturation is abrogated by infection-induced apoptosis of transitional B cells of both the T1 and T2 populations which is not uniquely dependent on TNF-, Fas-, or prostaglandin-dependent death pathways. Results obtained from ex vivo co-cultures of living bloodstream form trypanosomes and splenocytes demonstrate that trypanosome surface coat-dependent contact with T1/2 B cells triggers their deletion. We conclude that infection-induced and possibly parasite-contact dependent deletion of transitional B cells prevents replenishment of mature B cell compartments during infection thus contributing to a loss of the host's capacity to sustain antibody responses against recurring parasitemic waves.

Vyšlo v časopise: Infection Reduces B Lymphopoiesis in Bone Marrow and Truncates Compensatory Splenic Lymphopoiesis through Transitional B-Cell Apoptosis. PLoS Pathog 7(6): e32767. doi:10.1371/journal.ppat.1002089
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002089

Souhrn

Zdroje

1. VickermanK 1989 Trypanosome sociology and antigenic variation. Parasitology 99Suppl.S37 47

2. VickermanK 1978 Antigenic variation in trypanosomes. Nature 273 613 617

3. PaysE 2006 The variant surface glycoprotein as a tool for adaptation in African trypanosomes. Microbes Infect 8 930 937

4. BorstP 2002 Antigenic variation and allelic exclusion. Cell 109 5 8

5. PaysE 1995 Antigenic variation and the problem of vaccines against African trypanosomes. Bull Mem Acad R Med Belg 150:123-131; discussion 131-125

6. LevineRFMansfieldJM 1984 Genetics of resistance to the African trypanosomes. III. Variant Specific antibody responses of H-2-compatible resistant and susceptible mice. J immunol 133 1564 1569

7. GuirnaldaPMurphyNBNolanDBlackSJ 2007 Anti-Trypanosoma brucei activity in Cape buffalo serum during the cryptic phase of parasitemia is mediated by antibodies. Int J Parasitol 37 1391 1399

8. RadwanskaMMagezSMichelAStijlemansBGeuskensM 2000 Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei. Infect Immun 68 848 860

9. RadwanskaMGuirnaldaPDe TrezCRyffelBBlackSJ 2008 Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathog 4 e1000078 doi:10.1371/journal.ppat.1000078

10. CorsiniACClaytonCAskonasBAOgilvieBM 1977 Suppressor cells and loss of B-cell potential in mice infected with Trypanosoma brucei. Clin Exp Immunol 29 122 131

11. Mayor-WitheyKSClaytonCERoelantsGEAskonasBA 1978 Trypanosomiasis leads to extensive proliferation of B, T and null cells in spleen and bone marrow. Clin Exp Immunol 34 359 363

12. DiffleyP 1983 Trypanosomal surface coat variant antigen causes polyclonal lymphocyte activation. J Immunol 131 1983 1986

13. ClaytonCESelkikrMECorsiniCAOgilvieBMAskonasBA 1980 Murine trypanosomiasis: cellular proliferation and functional depletion in the blood, peritoneum, and spleen related to changes in bone marrow stem cells. Infect Immun 28 824 831

14. MaQJonesDSpringerTA 1999 The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10 463 471

15. NagasawaT 2006 Microenvironmental niches in the bone marrow required for B cell development. Nat Rev Immunol 6 107 116

16. KondoMSchererDCMiyamotoTKingAGAkashiK 2000 Cell-fate conversion of lymphoid-commited progenitors by instructive actions of cytokines. Nature 407 383 386

17. Montecino-RodriguezEDorshkindK 2003 To T or not to T: reassessing the common lymphoid progenitor. Nat Immunol 4 100 101

18. VitettaESUhrJW 1975 Immunoglobulin receptors revised. Science 189 964 969

19. AbneyERCooperMDKearneyJFLawtonARParkhouseRME 1978 Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J. Immunol. 120 2041 2049

20. UedaYYangKFosterSJKondoMKelsoeG 2004 Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. J Exp Med 199 47 57

21. CainDKondoMChenHKelsoeG 2009 Effects of acute and chronic inflammation on B-cell development and differentiation. J Invest Dermatol 129 266 277

22. SrivastavaBLindsleyRCNikbakhtNAllmanD 2005 Models for peripheral B cell development and homeostasis. Semin Immunol 17 175 182

23. TeagueBNPanYMuddPANakkenBZhangQ 2007 Cutting edge: Transitional T3 B cells do not give rise to mature B cells, have undergone selection, and are reduced in murine lupus. J Immunol 178 7511 7515

24. Labrie JE3rdSahAPAllmanDMCancroMPGersteinRM 2004 Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J Exp Med 200 411 423

25. AllmanDLindsleyRCDeMuthWRuddKShintonSA 2001 Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 167 6834 40

26. GorelikLCutlerAHThillGMiklaszSDSheaDE 2004 Cutting Edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol 172 762 766

27. ZunigaEMotranCCMontesCLYagitaHGruppiA 2002 Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide. J Immunol 168 3965 3973

28. ZunigaEMotranCCMontesCLYagitaHGruppiA 2002 Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide. J Immunol 168 3965 3973

29. FigarellaKRawerMUzcateguiNLKubataBKLauberK 2005 Prostaglandin D2 induced programmed cell death in Trypanosoma brucei bloodstream form. Cell Death Differ 12 335 346

30. MonroeJGBannishGFuentes-PananaEMKingLBSandelPC 2003 Positive and negative selection during B cell development. Immunologic research 27 427 442

31. MelamedDBenschopRJCambierJCNemazeeD 1998 Developmental regulation of B lymphocyte immune tolerance compartementalizes clonal selection from receptor selection. Cell 92 173 182

32. SaterRASandelPCMonroeJG 1998 B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Int Immunol 10 1673 1682

33. Castanos-VelezEMaerlanSOsorioLMBiberfeldPOmARottenbergME 1998 Trypanosoma cruzi infection in tumor receptor p55-deficient mice. Infect. Immun. 66 2960 2968

34. NagataS 1997 Apoptosis by death factor. Cell 88 355 365

35. KrammerPH 2000 CD95's deadly mission in the immune system. Nature 407 789 795

36. AshkenaziADixitVM 1999 Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 11 255 260

37. MicheauOTschoppJ 2003 Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 181 190

38. MagezSTruyensCMerimiMRadwanskaMStijlemansB 2004 P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J Infect Dis 189 527 539

39. DrennanMBStijlemansBVan den AbbeeleJQuesniauxVJBarkhuizenM 2005 The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J Immunol 175 2501 2509

40. LucasRMagezSSongaBDarjiAHamersR 1993 A role for TNF during African trypanosomiasis: involvement in parasite control, immunosuppression and pathology. Res Immunol 144 370 376

41. MagezSRadwanskaMBeschinASekikawaKDe BaetselierP 1999 Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect Immun 67 3128 3132

42. MagezSStijlemansBBaralTDe BaetselierP 2002 VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect 4 999 1006

43. MoriTAndoKTanakaKIkedaYKogaY 1997 Fas-mediated apoptosis of hematopoietic progenitor cells in mice infected with murine cytomegalovirus. Blood 89 3565 3573

44. CohenPLEisenbergRA 1991 Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9 243 269

45. PasqualettoVVasseurFZavalaFSchneiderEEzineS 2005 Fas receptor signaling is requisite for B cell differentiation. J Leukoc Biol 78 1106 1117

46. TakahashiYOhtaHTakemoriT 2001 Fas is required for colonal selection in germinal centers and the subsequent establishment of the memory B cell repertoire. Immunity 14 181 192

47. TannerJEAlfieriC 1999 Epstein-Barr virus induces Fas (CD95) in Tcells and Fas ligand in B cells leading to T-cell apoptosis. Blood 94 3439 3447

48. HahneMRennoTSchroeterMIrmlerMFrenchL 1996 Activated B cells express functional Fas ligand. Eur J Immunol 26 721 724

49. RadwanskaMBockstalVBrombacherFBlackSMagezS 2010 Parasite-induced B-cell apoptosis results in loss of specific protective anti-trypanosome antibody responses, and abolishment of vaccine induced protective memory responses. XII International Congress of Parasitology – ICOPA.In press

50. StijlemansBConrathKCortez-RetamozoVVan XongHWynsL 2004 Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem 279 1256 1261

51. Van MeirvenneNMagnusEBusherP 1995 Evaluation of variant specific trypanolysis tests for serodiagnosis of human infections with Trypanosoma brucei gambiense. Acta Trop 60 189 199

52. BlahaMDLeonLR 2008 Effects of indomethacin and buprenorphine analgesia on the postoperative recovery of mice. J Am Assoc Lab Anim Sci 47 8 19

53. MontineKSMontineTJMorrowJDFreiBMilatovicD 2002 Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment. Brain Res 930 75 82

54. SchleiferKWMansfieldJM 1993 Suppressor macrophages in African Trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol 151 5492 5503

55. SilvermanGJGoodyearCS 2006 Confounding B-cell defenses: lessons from a staphylococcal superantigen. Nat Rev Immunol 6 465 475

56. GoodyearCSCorrMSugiyamaFBoyleDLSilvermanGJ 2007 Cutting Edge: Bim is required for superantigen-mediated B cell death. J Immunol 178 2636 2640

57. PetroJBGersteinRMLoweJCarterRSShinnersN 2002 Transitional type 1 and 2 B lymphocyte subsets are differentially responsive to antigen receptor signaling. J Biol Chem 277 48009 48019

58. SuTTRawlingsDJ 2002 Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development. J Immunol 168 2101 2110

59. YoshidaTHiguchiTHagiyamaHStrasserANishiokaK 2000 Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/Apo-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-lpr/lpr mice. Int Immunol 12 517 526

60. De GroeveKDeschachtNDe KoninckCCaveliersVLahoutteT 2010 Nanobodies as tools for in vivo imaging of specific immune cell types. J Nucl Med 51 782 789

61. MagezSSchwegmannAAtkinsonRClaesFDrennanM 2008 The role of B cells and IgM antibodies in parasitemia, anemia and VSG switching in Trypanosoma brucei-infected mice. PLoS Pathog 4 e1000122

62. MagezSRadwanskaM 2009 African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis. Future Microbiol 4 1075 1087

63. LanhamSMGodfreyDG 1970 Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp Parasitol 28 521 534